P1‐024: CHARACTERIZATION OF A NOVEL GROUP OF PHOSPHODIESTERASE 9A INHIBITORS AS PUTATIVE THERAPEUTICS FOR COGNITIVE DYSFUNCTION. (1st July 2014)